|
Gender, female
|
1.87 (1.07–3.28)
|
0.029
|
1.96 (0.98–3.91)
|
0.057
|
|
Not using an asthma action plan
|
2.15 (1.2–3.84)
|
0.01
|
2.22 (1.09–4.49)
|
0.027
|
|
Atopy status
|
1.13 (0.63–2.02)
|
0.674
|
–
|
–
|
|
Cause of the exacerbation
|
|
Infection versus non-infectious cause
|
1.53 (0.85–2.73)
|
0.153
|
1.65 (0.81–3.36)
|
0.169
|
|
Allergen versus non-allergenic cause
|
0.58 (0.19–1.72)
|
0.323
|
–
|
–
|
|
Non-adherence to prescribed therapy versus adherence
|
0.87 (0.45–1.68)
|
0.671
|
–
|
–
|
|
Duration of asthma
|
|
< 1 year versus > 1 year
|
0.69 (0.37–1.27)
|
0.233
|
–
|
–
|
|
1–2 years versus < 1 year and > 2 years
|
1.04 (0.57–1.87)
|
0.904
|
–
|
–
|
|
> 2 years versus < 2 years
|
0.68 (0.34–1.37)
|
0.28
|
–
|
–
|
|
Biomarkers
|
|
Blood eosinophil count \(\ge\) 298 versus < 298
|
8.87 (4.73–16.62)
|
< 0.001
|
8.79 (4.44–17.4)
|
< 0.001
|
|
NLR \(\ge\) 2.52 versus < 2.52
|
3.04 (1.72–5.35)
|
< 0.001
|
2.13 (1.09–4.14)
|
0.027
|